Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 USD | +9.55% | +3.51% | +35.41% |
May. 01 | Transcript : G1 Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
May. 01 | Earnings Flash (GTHX) G1 THERAPEUTICS Reports Q1 Revenue $14.5M, vs. Street Est of $15.1M | MT |
Financials (USD)
Sales 2024 * | 68.9M | Sales 2025 * | 102M | Capitalization | 197M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -20M | EV / Sales 2024 * | 2.86 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
-6.2
x | P/E ratio 2025 * |
-14.7
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.3% |
Latest transcript on G1 Therapeutics, Inc.
1 day | +9.55% | ||
1 week | -1.43% | ||
Current month | +9.55% | ||
1 month | -4.40% | ||
3 months | +4.56% | ||
6 months | +150.30% | ||
Current year | +35.41% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bailey
CEO | Chief Executive Officer | 59 | 20-03-11 |
John Umstead
DFI | Director of Finance/CFO | - | 17-12-31 |
Rajesh K. Malik
CTO | Chief Tech/Sci/R&D Officer | 65 | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Muir
BRD | Director/Board Member | 65 | 15-08-31 |
Cynthia Flowers
BRD | Director/Board Member | 64 | 18-06-06 |
Norman Sharpless
FOU | Founder | 57 | 08-05-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 509 M€ | -.--% | ||
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 4.13 | +9.55% | 1,007,045 |
24-04-30 | 3.77 | +1.34% | 528,648 |
24-04-29 | 3.72 | -6.77% | 691,138 |
24-04-26 | 3.99 | +3.37% | 441,518 |
24-04-25 | 3.86 | -3.26% | 538,433 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.41% | 197M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- GTHX Stock